SUPN
Supernus Pharmaceuticals, Inc.$48.30-1.16 (-2.35%)Prev Close$49.46·MCap$2.87B·P/E—·Vol256.6K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
29
$28.71M
◆
Net Activity
Net Seller
$28.71M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Supernus Pharmaceuticals, Inc. (SUPN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 29 insider sales totaling $28.71M. The most recent insider transaction was by Bhatt Padmanabh P. (officer: Sr. VP of IP, CSO), who sold $5.39M worth of shares on Mar 18, 2026. Supernus Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $2.87B.
SUPN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Bhatt Padmanabh P. | officer: Sr. VP of IP, CSO | Sell | 107,250 | $50.24 | $5.39M | 39,334-73% |
| Mar 16, 2026 | Hudson Frederick M. | director | Sell | 5,369 | $50.61 | $271.7K | 60,413 |
| Mar 16, 2026 | Khattar Jack A. | director, officer: President, CEO | Sell | 35,000 | $50.37 | $1.76M | 968,962 |
| Mar 10, 2026 | Horich William Todd | officer: SVP, Commercial Operations | Sell | 8,877 | $54.50 | $483.8K | 4,439-67% |
| Mar 10, 2026 | Mottola Frank | officer: SVP, Chief Tech. Ops. Officer | Sell | 1,623 | $53.65 | $87.1K | 18,440 |
| Mar 9, 2026 | GEMAYEL GEORGES | director | Sell | 18,787 | $53.38 | $1.00M | 28,159-40% |
| Feb 19, 2026 | Sensenig Bethany | Director | Sell | 4,475 | $51.01 | $228.3K | 0 |
| Dec 19, 2025 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | 20,000 | $50.41 | $1.01M | 0 |
| Dec 18, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 710 | $44.44 | $31.6K | 0 |
| Oct 9, 2025 | Khattar Jack A. | President, CEO | Sell | 59,900 | $50.57 | $3.03M | 0 |
| Oct 9, 2025 | NEWHALL CHARLES W III | Director | Sell | 25,000 | $50.77 | $1.27M | 0 |
| Oct 2, 2025 | Khattar Jack A. | President, CEO | Sell | 17,229 | $46.41 | $799.7K | 0 |
| Oct 1, 2025 | Khattar Jack A. | President, CEO | Sell | 40,173 | $48.07 | $1.93M | 0 |
| Sep 30, 2025 | Khattar Jack A. | President, CEO | Sell | 8,588 | $48.25 | $414.4K | 0 |
| Sep 29, 2025 | Khattar Jack A. | President, CEO | Sell | 10,235 | $48.02 | $491.5K | 0 |
| Sep 25, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | 840 | $46.21 | $38.8K | 0 |
| Sep 23, 2025 | Khattar Jack A. | President, CEO | Sell | 29,513 | $47.23 | $1.39M | 0 |
| Sep 22, 2025 | Khattar Jack A. | President, CEO | Sell | 16,587 | $47.02 | $779.9K | 0 |
| Sep 12, 2025 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | 5,000 | $45.87 | $229.3K | 0 |
| Sep 8, 2025 | Khattar Jack A. | President, CEO | Sell | 6,322 | $46.29 | $292.6K | 0 |
| Aug 25, 2025 | NEWHALL CHARLES W III | Director | Sell | 1,000 | $45.00 | $45.0K | 0 |
| Aug 25, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 14,000 | $44.51 | $623.1K | 0 |
| Aug 25, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 581 | $41.46 | $24.1K | 0 |
| Aug 22, 2025 | DEC TIMOTHY C | Senior Vice-President & CFO | Sell | 11,780 | $44.49 | $524.1K | 0 |
| Aug 22, 2025 | NEWHALL CHARLES W III | Director | Sell | 1,412 | $45.00 | $63.5K | 0 |
| Aug 22, 2025 | Khattar Jack A. | President, CEO | Sell | 1,500 | $45.00 | $67.5K | 0 |
| Aug 14, 2025 | Sensenig Bethany | Director | Sell | 5,369 | $42.25 | $226.8K | 0 |
| Aug 14, 2025 | Hudson Frederick M. | Director | Sell | 7,457 | $42.26 | $315.1K | 0 |
| Aug 6, 2025 | Khattar Jack A. | President, CEO | Sell | 140,000 | $42.02 | $5.88M | 0 |
| Mar 10, 2025 | DEC TIMOTHY C | Senior Vice-President & CFO | Sell | 2,017 | $32.06 | $64.7K | 0 |
| Mar 10, 2025 | Khattar Jack A. | President, CEO | Sell | 16,805 | $32.06 | $538.8K | 0 |
| Mar 7, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 1,356 | $39.11 | $53.0K | 0 |
| Mar 7, 2025 | Khattar Jack A. | President, CEO | Sell | 18,581 | $39.11 | $726.7K | 0 |
| Mar 5, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | 891 | $33.05 | $29.4K | 0 |
| Mar 5, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 1,892 | $33.05 | $62.5K | 0 |
| Mar 5, 2025 | DEC TIMOTHY C | Senior Vice-President & CFO | Sell | 3,193 | $33.05 | $105.5K | 0 |
| Mar 5, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 910 | $33.05 | $30.1K | 0 |
| Feb 26, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 2,885 | $39.48 | $113.9K | 0 |
| Feb 21, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 552 | $39.15 | $21.6K | 0 |
| Feb 21, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 860 | $39.15 | $33.7K | 0 |
| Feb 21, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | 927 | $39.15 | $36.3K | 0 |
| Feb 5, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 9,477 | $39.70 | $376.2K | 10,149-48% |
| Jan 29, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 3,273 | $39.62 | $129.7K | 10,149 |
| Dec 4, 2024 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 21,495 | $36.68 | $788.4K | 9,679-69% |
| Nov 12, 2024 | Hudson Frederick M. | Director | Sell | 8,722 | $36.28 | $316.4K | 28,395 |
| Nov 12, 2024 | Khattar Jack A. | President, CEO | Sell | 125,000 | $36.29 | $4.54M | 926,172 |
| Nov 12, 2024 | GEMAYEL GEORGES | Director | Sell | 10,787 | $36.30 | $391.6K | 13,315-45% |
| Nov 12, 2024 | NEWHALL CHARLES W III | Director | Sell | 10,700 | $36.24 | $387.8K | 130,275 |
| Nov 8, 2024 | GEMAYEL GEORGES | Director | Sell | 14,213 | $36.62 | $520.5K | 13,315-52% |
| Nov 8, 2024 | Khattar Jack A. | President, CEO | Sell | 125,000 | $36.68 | $4.58M | 926,172 |
Showing 1–50 of 88
1 / 2
SUPN Insider Buying Activity
The following table shows recent insider purchases of Supernus Pharmaceuticals, Inc. (SUPN) stock reported via SEC Form 4 filings.
No insider buying activity found for SUPN in the last 12 months.
SUPN Insider Selling Activity
The following table shows recent insider sales of Supernus Pharmaceuticals, Inc. (SUPN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Bhatt Padmanabh P. | officer: Sr. VP of IP, CSO | Sell | 107,250 | $50.24 | $5.39M | 39,334-73% |
| Mar 16, 2026 | Hudson Frederick M. | director | Sell | 5,369 | $50.61 | $271.7K | 60,413 |
| Mar 16, 2026 | Khattar Jack A. | director, officer: President, CEO | Sell | 35,000 | $50.37 | $1.76M | 968,962 |
| Mar 10, 2026 | Horich William Todd | officer: SVP, Commercial Operations | Sell | 8,877 | $54.50 | $483.8K | 4,439-67% |
| Mar 10, 2026 | Mottola Frank | officer: SVP, Chief Tech. Ops. Officer | Sell | 1,623 | $53.65 | $87.1K | 18,440 |
| Mar 9, 2026 | GEMAYEL GEORGES | director | Sell | 18,787 | $53.38 | $1.00M | 28,159-40% |
| Feb 19, 2026 | Sensenig Bethany | Director | Sell | 4,475 | $51.01 | $228.3K | 0 |
| Dec 19, 2025 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | 20,000 | $50.41 | $1.01M | 0 |
| Dec 18, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 710 | $44.44 | $31.6K | 0 |
| Oct 9, 2025 | Khattar Jack A. | President, CEO | Sell | 59,900 | $50.57 | $3.03M | 0 |
| Oct 9, 2025 | NEWHALL CHARLES W III | Director | Sell | 25,000 | $50.77 | $1.27M | 0 |
| Oct 2, 2025 | Khattar Jack A. | President, CEO | Sell | 17,229 | $46.41 | $799.7K | 0 |
| Oct 1, 2025 | Khattar Jack A. | President, CEO | Sell | 40,173 | $48.07 | $1.93M | 0 |
| Sep 30, 2025 | Khattar Jack A. | President, CEO | Sell | 8,588 | $48.25 | $414.4K | 0 |
| Sep 29, 2025 | Khattar Jack A. | President, CEO | Sell | 10,235 | $48.02 | $491.5K | 0 |
| Sep 25, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | 840 | $46.21 | $38.8K | 0 |
| Sep 23, 2025 | Khattar Jack A. | President, CEO | Sell | 29,513 | $47.23 | $1.39M | 0 |
| Sep 22, 2025 | Khattar Jack A. | President, CEO | Sell | 16,587 | $47.02 | $779.9K | 0 |
| Sep 12, 2025 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | 5,000 | $45.87 | $229.3K | 0 |
| Sep 8, 2025 | Khattar Jack A. | President, CEO | Sell | 6,322 | $46.29 | $292.6K | 0 |
| Aug 25, 2025 | NEWHALL CHARLES W III | Director | Sell | 1,000 | $45.00 | $45.0K | 0 |
| Aug 25, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 14,000 | $44.51 | $623.1K | 0 |
| Aug 25, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 581 | $41.46 | $24.1K | 0 |
| Aug 22, 2025 | DEC TIMOTHY C | Senior Vice-President & CFO | Sell | 11,780 | $44.49 | $524.1K | 0 |
| Aug 22, 2025 | NEWHALL CHARLES W III | Director | Sell | 1,412 | $45.00 | $63.5K | 0 |
| Aug 22, 2025 | Khattar Jack A. | President, CEO | Sell | 1,500 | $45.00 | $67.5K | 0 |
| Aug 14, 2025 | Sensenig Bethany | Director | Sell | 5,369 | $42.25 | $226.8K | 0 |
| Aug 14, 2025 | Hudson Frederick M. | Director | Sell | 7,457 | $42.26 | $315.1K | 0 |
| Aug 6, 2025 | Khattar Jack A. | President, CEO | Sell | 140,000 | $42.02 | $5.88M | 0 |
| Mar 10, 2025 | DEC TIMOTHY C | Senior Vice-President & CFO | Sell | 2,017 | $32.06 | $64.7K | 0 |
| Mar 10, 2025 | Khattar Jack A. | President, CEO | Sell | 16,805 | $32.06 | $538.8K | 0 |
| Mar 7, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 1,356 | $39.11 | $53.0K | 0 |
| Mar 7, 2025 | Khattar Jack A. | President, CEO | Sell | 18,581 | $39.11 | $726.7K | 0 |
| Mar 5, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | 891 | $33.05 | $29.4K | 0 |
| Mar 5, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 1,892 | $33.05 | $62.5K | 0 |
| Mar 5, 2025 | DEC TIMOTHY C | Senior Vice-President & CFO | Sell | 3,193 | $33.05 | $105.5K | 0 |
| Mar 5, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 910 | $33.05 | $30.1K | 0 |
| Feb 26, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 2,885 | $39.48 | $113.9K | 0 |
| Feb 21, 2025 | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | 552 | $39.15 | $21.6K | 0 |
| Feb 21, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 860 | $39.15 | $33.7K | 0 |
| Feb 21, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | 927 | $39.15 | $36.3K | 0 |
| Feb 5, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 9,477 | $39.70 | $376.2K | 10,149-48% |
| Jan 29, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 3,273 | $39.62 | $129.7K | 10,149 |
| Dec 4, 2024 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | 21,495 | $36.68 | $788.4K | 9,679-69% |
| Nov 12, 2024 | Hudson Frederick M. | Director | Sell | 8,722 | $36.28 | $316.4K | 28,395 |
| Nov 12, 2024 | Khattar Jack A. | President, CEO | Sell | 125,000 | $36.29 | $4.54M | 926,172 |
| Nov 12, 2024 | GEMAYEL GEORGES | Director | Sell | 10,787 | $36.30 | $391.6K | 13,315-45% |
| Nov 12, 2024 | NEWHALL CHARLES W III | Director | Sell | 10,700 | $36.24 | $387.8K | 130,275 |
| Nov 8, 2024 | GEMAYEL GEORGES | Director | Sell | 14,213 | $36.62 | $520.5K | 13,315-52% |
| Nov 8, 2024 | Khattar Jack A. | President, CEO | Sell | 125,000 | $36.68 | $4.58M | 926,172 |
SUPN Insiders
Similar Stocks to SUPN
ZTS
Zoetis Inc.
$117.47-0.31%
$51.80B
VTRS
Viatris Inc.
$14.70-0.73%
$17.15B
NBIX
Neurocrine Biosciences, Inc.
$127.75-0.23%
$13.07B
INDV
Indivior Pharmaceuticals Inc
$34.44+0.36%
$4.15B
PAHC
Phibro Animal Health Corporation
$54.56-2.81%
$2.19B
ANIP
ANI Pharmaceuticals, Inc.
$78.47-1.42%
$1.79B
PRGO
Perrigo Company plc
$11.57+0.74%
$1.61B
HROW
Harrow Health, Inc.
$40.23-2.97%
$1.44B